By Our Business Correspondent
India’s equity markets staged a dramatic late-session recovery on Wednesday, clawing back steep intraday losses as investors returned to accumulate battered stocks at lower valuations. Yet the rebound was not enough to fully erase concerns over global uncertainty, rising crude oil prices and persistent pressure on heavyweight technology counters.
After opening weak and extending losses through the morning session, benchmark indices found support from selective buying in oversold pockets of the market. The recovery helped restore confidence, but caution remained visible as investors weighed geopolitical risks and their potential impact on inflation, capital flows and corporate earnings.
The Nifty 50, which had slipped to an intraday low of 23,151.50, rebounded nearly 250 points during the second half of trade and briefly reclaimed the 23,400 level before closing at 23,405.60, down 77.95 points or 0.33%. The S&P BSE Sensex lost 303.67 points or 0.41% to settle at 74,346.17.
Market participants said bargain hunting emerged after the sharp correction, particularly in quality names that had witnessed heavy selling in recent sessions. However, uncertainty around evolving geopolitical developments in the Middle East continued to limit risk appetite.
The key overhang remained speculation surrounding efforts to secure a ceasefire understanding between the United States and Iran, with developments keeping global energy markets volatile. Brent crude prices surged close to the $100-per-barrel mark, intensifying concerns that elevated fuel costs could revive inflationary pressures and complicate central bank policy outlooks.
Despite the intraday rebound, market breadth reflected underlying weakness. Declining stocks significantly outnumbered advancing counters, indicating that broader investor sentiment remained fragile.
On the Bombay Stock Exchange, 2,732 stocks declined against 1,573 advances, while 217 remained unchanged.
Technology Stocks Trigger Market Pressure
The day’s biggest drag came from information technology majors, which erased recent gains and pulled benchmark indices lower.
Tata Consultancy Services (TCS) plunged 8.39%, emerging as the largest loser on the benchmark despite announcing an expansion of its partnership with Euroclear Group to support the transformation of Sweden’s Central Securities Depository infrastructure.
HCL Technologies declined 5.19%, while Infosys lost 3.79%, triggering broad-based weakness across the technology sector.
Analysts said investors booked profits after recent gains while reassessing global growth expectations and overseas technology spending trends.
Meanwhile, defensive FMCG counters also remained under pressure, preventing a stronger market rebound.
Broader Market Signals Remain Mixed
Broader indices underperformed frontline benchmarks, highlighting caution among retail and domestic institutional investors.
The BSE MidCap Index declined 0.50%, while the SmallCap Index managed to close marginally higher by 0.01%.
Volatility expectations also increased. The India VIX, often referred to as the market’s fear gauge, climbed 6% to 16.28, indicating rising investor demand for downside protection.
Technical analysts believe markets remain vulnerable despite the recovery.
Immediate support for the Nifty is seen around 23,300, while a decisive move above 23,600 may be required to revive bullish momentum.
Services Economy Offers a Bright Spot
Providing some support to sentiment, fresh macroeconomic data pointed to continued resilience in India’s domestic economy.
The HSBC India Services PMI was revised upward to 59.8 in May 2026, improving from the preliminary estimate of 58.9 and above April’s reading of 58.8.
The data suggested a stronger expansion in services activity, supported by healthy order inflows and a notable rebound in overseas demand after weakness in April.
Importantly, easing input cost inflation reduced pricing pressure, offering relief to businesses navigating a still uncertain global environment.
Markets Track Bonds, Currency and Commodities
Financial markets also reflected growing caution.
India’s benchmark 10-year government bond yield edged higher to 7.025%, indicating concerns over inflation and borrowing costs.
The rupee weakened modestly against the U.S. dollar to 95.6775, compared with 95.3650 in the previous session.
Gold prices softened, with MCX Gold futures falling 0.93% to Rs 154,100, while the U.S. Dollar Index strengthened to 99.35.
Brent crude rose 2.45% to $98.35 per barrel, reinforcing concerns over imported inflation risks.
Corporate Movers Reflect Stock-Specific Action
Outside benchmark names, stock-specific developments drove sharp moves.
John Cockerill India surged 20% after securing orders worth approximately Rs 1,250–1,300 crore from JSW Vijayanagar Metallics.
Varroc Engineering gained after announcing a strategic partnership with China’s TOLYY OPTRONICS to localise digital cockpit display solutions.
Concord Biotech advanced following U.S. regulatory approval for its immunosuppressant product.
Among laggards, IndusInd Bank declined amid reports of a whistleblower complaint linked to governance concerns, although the bank clarified it had received no regulatory communication and stated that appropriate actions had already been taken.
Zydus Lifesciences remained under pressure after receiving a warning letter from the USFDA related to records compliance.
Global Markets Watch Middle East and Trade Risks
Globally, investor sentiment remained divided.
European markets traded lower amid concerns over proposed U.S. tariff measures, while most Asian markets ended in positive territory.
Wall Street, however, continued its record-setting run overnight, with the S&P 500, Dow Jones, and Nasdaq ending near historic highs despite geopolitical uncertainty.
For Indian investors, the message from Wednesday’s session was clear: domestic fundamentals remain supportive, but global risks — especially energy prices, geopolitics and currency volatility — continue to dictate market direction.
Disclaimer: Stock market investments are subject to market risks. Please consult with a certified financial advisor before making any investment decisions.